Stephen Hall

Lund University — Sweden

Medicine · Health Sciences

51h-index14.8kcitations255works11.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(81), Autoimmune and Inflammatory Disorders Research(44), Particle physics theoretical and experimental studies(39), Spondyloarthritis Studies and Treatments(39), Quantum Chromodynamics and Particle Interactions(34)

Publications211 total

Efficacité à 1 an du bimekizumab chez les patients atteints de spondyloarthrite axiale non-radiographique : Stratification par statuts IRM et CRP à l’inclusion
Revue du Rhumatisme·2025
Early gigantic lamniform marks the onset of mega-body size in modern shark evolution
Communications Biology·2025· 1 citedOpen Access
Benefit–risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease
RMD Open·2025· 2 citedOpen Access
The SENCo role across ages and settings
2025
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study
RMD Open·2024· 7 citedOpen Access
Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single‐centre Australian practice
Internal Medicine Journal·2024
Citizen hydrospatial sciences - To csB or not to csB, that is the question!
The International Hydrographic Review·2024· 1 citedOpen Access
Tofacitinib efficacy, patient‐reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase <scp>III</scp> studies
Journal of the European Academy of Dermatology and Venereology·2024· 4 citedOpen Access
Magnetic resonance imaging RAMRIS‐SAFE score—A low‐risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials
International Journal of Rheumatic Diseases·2023· 2 citedOpen Access
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
Arthritis Research & Therapy·2023· 19 citedOpen Access
E089 Effect of secukinumab on radiographic progression and inflammation in sacroiliac joints and spine in patients with non-radiographic axial spondyloarthritis: 2-year imaging outcomes from a Phase III randomised trial
Lara D. Veeken·2023Open Access
Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study
Advances in Therapy·2022· 4 cited
Certolizumab Pegol Efficacy in Patients With <scp>Non‐Radiographic</scp> Axial Spondyloarthritis Stratified by Baseline <scp>MRI</scp> and <scp>C‐Reactive</scp> Protein Status: An Analysis From the <scp>C‐axSpAnd</scp> Study
ACR Open Rheumatology·2022· 7 citedOpen Access
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program
Lara D. Veeken·2021· 12 citedOpen Access
Le sécukinumab améliore durablement les symptômes de spondyloarthrite axiale non-radiographique : résultats à 2 ans de l’étude PREVENT
Revue du Rhumatisme·2021
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT
Arthritis Research & Therapy·2021· 42 citedOpen Access
POS0900 SECUKINUMAB 150 MG PROVIDES SUSTAINED IMPROVEMENT IN SIGNS AND SYMPTOMS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM THE PREVENT STUDY
Annals of the Rheumatic Diseases·2021· 3 cited
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)
Rheumatology and Therapy·2020· 17 citedOpen Access
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases·2020· 25 citedOpen Access
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study
Arthritis & Rheumatology·2020· 151 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Rachelle Buchbinder(9), Mark C. Genovese(7), Peter Nash(7), Philip J. Mease(6), Roy Fleischmann(5), Arthur Kavanaugh(5), Alan Kivitz(4), Hasan Tahir(4), Shephard Mpofu(4), Patrick Durez(3), Sriram Krishnaswami(3), Edward Keystone(3), Pedro C. Miranda(3), Sang‐Cheol Bae(3), Mahboob U. Rahman(3), Eduardo Mysler(3), Andrea Rubbert‐Roth(3), Ricardo Blanco(3), Alain Cantagrel(3), Elizabeth C. Hsia(3)